Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Clinical Research

Chemopreventive effects of a bioadhesive berry gel on lesions of oral epithelial dysplasia

Susan Mallery, Peter Larsen, Henry Fields, Russell Mumper and Gary Stoner
Susan Mallery
Ohio State Univ., Columbus, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Larsen
Ohio State Univ., Columbus, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Henry Fields
Ohio State Univ., Columbus, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Russell Mumper
Ohio State Univ., Columbus, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gary Stoner
Ohio State Univ., Columbus, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published May 2007
  • Article
  • Info & Metrics
Loading
AACR Annual Meeting-- Apr 14-18, 2007; Los Angeles, CA

Abstract

LB-175

Early detection of precancerous oral lesions combined with effective local intervention is a rational strategy to prevent lesion progression to squamous cell carcinoma (SCC). This study assessed therapeutic efficacy of a topically applied bioadhesive gel that contains 10% (w/w) freeze dried black raspberries on oral dysplastic lesions. Patients with histories of recurrent oral dysplastic lesions were targeted for enrollment into the trial. None of the participants were current smokers, or had used tobacco within 6 weeks of study participation. Each patient served as their own internal control. The oral lesions were hemisected, leaving half of the lesional tissue in situ for treatment (topical application q.i.d. for six weeks, 1 gram total daily dose) with the berry gel. Evaluative parameters included: histopathologic diagnoses, image analysis quantified immunohistochemistry (IHC), modulation of gene expression (microarray analyses), and return of heterozygosity. A representative portion of the initial and post treatment biopsy was submitted for light microscopy (to confirm the diagnosis and IHC studies) while the remainder was snap frozen for microarray analyses, RT-PCR validation, and loss of heterozygosity studies. Histopathological diagnoses were provided by two board certified oral pathologists. The summary of pre and post treatment microscopic diagnoses for the 17 persons who completed the study is: no change in microscopic diagnosis=6, increase in lesional grade=4, decrease in lesional grade=7. One participant, who had received 3 previous diagnoses of mild epithelial dysplasia at the treatment site, had complete lesional regression. IHC revealed that 11 of the 14 tissues analyzed showed a decrease (mean=21% ± 4 s.e.m.) in cyclooxygenase 2 (COX-2) protein following treatment (p<0.05, Chi Square). Six of the 7 participants who showed a decrease in histologic grade also showed a decrease in COX-2 protein. Nine of 15 tissues analyzed demonstrated a post treatment decrease (16.9% + 3.9) in epithelial iNOS; 6 of these 9 tissues also showed a decrease in histologic grade. Microarray analyses revealed a post treatment: 1) decrease in expression in all 13 tissues analyzed in genes associated with inhibition of apoptosis, recycling of growth factors, chromosomal rearrangement, and RNA processing, and an 2) increase in expression of genes associated with keratinocyte cornified envelope formation/terminal differentiation, cell adhesion, apoptosis, cytoprotection and negative control of cell growth and division. Ongoing RT-PCR analyses showed increased expression of genes such as desmocollin and cytokeratin 2 associated with keratinocyte differentiation. These data show that despite a short (6 week) duration, berry gels demonstrate chemopreventive efficacy, which results in stable or improved grade in 76% of the oral lesions. Research supported by NIH R21 CA11121.

Footnotes

  • 98th AACR Annual Meeting-- Apr 14-18, 2007; Los Angeles, CA

  • American Association for Cancer Research
Previous
Back to top
Cancer Research: 67 (9 Supplement)
May 2007
Volume 67, Issue 9 Supplement
  • Table of Contents
  • Index by Author

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Chemopreventive effects of a bioadhesive berry gel on lesions of oral epithelial dysplasia
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Chemopreventive effects of a bioadhesive berry gel on lesions of oral epithelial dysplasia
Susan Mallery, Peter Larsen, Henry Fields, Russell Mumper and Gary Stoner
Cancer Res May 1 2007 (67) (9 Supplement) LB-175;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Chemopreventive effects of a bioadhesive berry gel on lesions of oral epithelial dysplasia
Susan Mallery, Peter Larsen, Henry Fields, Russell Mumper and Gary Stoner
Cancer Res May 1 2007 (67) (9 Supplement) LB-175;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

Clinical Research

  • Abstract SY20-03: Novel radiotracers for clinical molecular imaging in oncology
  • Abstract PL01-02: The Breast International Group (BIG): Building on an accelerated path to tailored adjuvant cancer therapy
  • Abstract SS02-04: How much can we afford to pay for new drugs, and how do we make those decisions?
Show more 3

Head and neck cancers: Poster Presentations - Late-Breaking Abstracts

  • Examining expression of folate receptors in squamous cell carcinoma of the head and neck (SCCHN) as a target for a novel nanotherapeutic drug
Show more 3
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement